GE Warned Over Misleading Claims on Imaging Drug
The Food and Drug Administration has warned General Electric Co’s healthcare unit about misleading claims the company made about one of its medical imaging drugs on a promotional website.
Continue →MRI Contrast Agents Face First Trial Over Link to Skin Disorder
Next month, the first of many lawsuits filed against makers of medical imaging contrast agents linked to a potentially fatal skin-thickening disorder called nephrogenic systemic fibrosis (NSF) is scheduled to begin.
Continue →Restrict Use of Gadolinium Contrast Agents, FDA Panel Says
The use of gadolinium contrast agents during medical imaging scans should be restricted because of an apparent link to a potentially fatal skin-hardening disease, a Food and Drug Administration advisory panel has ruled, according to a CNNmoney.com report.
Continue →Use of MRI Scan Agents Linked to Deadly Skin Disorder, NSF
Chemical agents used to enhance the results of MRI scans appear to cause a severe and possibly deadly type of skin infection, called nephrogenic system fibrosis (NSF). People diagnosed with the condition most often develop red patches of thick and hardened skin, especially on their legs, arms, and hands. The progressive disorder worsens over time and can turn fatal if not treated properly.
Continue →
facebook
rss
twitter